UBS Group’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $580K | Buy |
87,613
+41,441
| +90% | +$274K | ﹤0.01% | 4731 |
|
|
2025
Q1 | $422K | Buy |
46,172
+7,682
| +20% | +$70.3K | ﹤0.01% | 4792 |
|
|
2024
Q4 | $404K | Buy |
38,490
+4,114
| +12% | +$43.2K | ﹤0.01% | 4834 |
|
|
2024
Q3 | $411K | Buy |
34,376
+21,600
| +169% | +$258K | ﹤0.01% | 4222 |
|
|
2024
Q2 | $73.5K | Buy |
12,776
+11,471
| +879% | +$66K | ﹤0.01% | 5253 |
|
|
2024
Q1 | $6.79K | Sell |
1,305
-1,071
| -45% | -$5.57K | ﹤0.01% | 6263 |
|
|
2023
Q4 | $12.5K | Sell |
2,376
-1,902
| -44% | -$10K | ﹤0.01% | 6141 |
|
|
2023
Q3 | $14.1K | Buy |
4,278
+2,469
| +136% | +$8.15K | ﹤0.01% | 5830 |
|
|
2023
Q2 | $5.23K | Sell |
1,809
-13,918
| -88% | -$40.2K | ﹤0.01% | 6380 |
|
|
2023
Q1 | $16.8K | Buy |
15,727
+2,983
| +23% | +$3.19K | ﹤0.01% | 6118 |
|
|
2022
Q4 | $33.3K | Buy |
12,744
+5,372
| +73% | +$14K | ﹤0.01% | 5967 |
|
|
2022
Q3 | $51K | Buy |
7,372
+3,462
| +89% | +$24K | ﹤0.01% | 5264 |
|
|
2022
Q2 | $27K | Sell |
3,910
-1,198
| -23% | -$8.27K | ﹤0.01% | 5473 |
|
|
2022
Q1 | $72K | Sell |
5,108
-8,485
| -62% | -$120K | ﹤0.01% | 5133 |
|
|
2021
Q4 | $197K | Buy |
+13,593
| New | +$197K | ﹤0.01% | 4663 |
|
|
2021
Q3 | – | Sell |
-1,753
| Closed | -$31K | – | 8374 |
|
|
2021
Q2 | $31K | Sell |
1,753
-2,535
| -59% | -$44.8K | ﹤0.01% | 5797 |
|
|
2021
Q1 | $66K | Buy |
+4,288
| New | +$66K | ﹤0.01% | 5279 |
|